NCT06438588View on ClinicalTrials.gov

Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

March 15, 2027

Study Completion Date

March 15, 2027

Conditions
Advanced Malignant Solid Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood sample collection

OTHER

Dietary Intervention

Given FMD

OTHER

Educational Intervention

Receive educational guidelines

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Interview

Ancillary studies

OTHER

Nutritional Assessment

Receive nutrition counseling

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06438588 - Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial | Biotech Hunter | Biotech Hunter